Etnia Barcelona has jumped on the Japan aesthetics trend with the launch of the Miscelánea collection. The collection and surrealist campaign stands out for its intriguing combination of two worlds, with natural acetates and Japanese-inspired textures combined with bold Mediterranean shapes.
Celebrating successes and sharing learning, OPSM’s 2023 Eyecare Roadshow ‘The Evolving Lens’ covered the remarkable strides and innovations characterising eyecare over the past decade, said New Zealand country eyecare manager Tegan Matheson. “It recognised the profound desire for exceptional patient
A daily 20mg dietary-zeaxanthin supplement decreased unilateral neovascular age-related macular degeneration (nAMD) patients’ chances of developing AMD in the second eye by 54%, representing a potential 1,531% return-on-investment, reported US researchers.
The Optical Distributors and Manufacturers Association (ODMA) is bringing its smaller, biennial OShow optical fair back to Sydney’s iconic Hordern Pavilion in Moore Park from 17-18 May 2024.
Speaking to a packed auditorium at O=Mega23/WCO4 in Melbourne, Noel Brennan unveiled Johnson and Johnson Vision’s (J&Js) latest, self-proclaimed “breakthrough soft contact lens for myopia control”.
Back from a four-year hiatus, the Optical Distributors and Manufacturers Association (ODMA) Awards for Excellence were announced before a large audience at the combined O=Mega23 optical fair and 4th World Congress of Optometry conference in Melbourne.
A new international clinical trial of two strategies to treat Acanthamoeba keratitis (AK) found they each cured 87% of patients. Led by Professor John Dart, UCL Institute of Ophthalmology and
Ocuphire Pharma announced the US Food and Drug Administration (FDA) has approved Ryzumvi (phentolamine ophthalmic solution) 0.75% eye drops for the treatment of pharmacologically induced mydriasis.
National University of Singapore researchers found consuming grapes for 16 weeks improved key markers of eye health in older adults. With oxidative stress identified as a key risk factor for visual
A North American case series demonstrated intraocular methotrexate (MTX) eradicated the sheet-like form of epithelial downgrowth (EDG) in 70% of treated eyes. Writing in the British Journal of
Dutch researchers studying primary open-angle glaucoma (POAG) patients with high intraocular pressures said their results suggest a genetic deficiency in mitochondrial DNA (mtDNA) replication may play
Researchers in Switzerland found a smartphone app performed better than a Hertel exophthalmometer for measuring exophthalmos¹. Based at the University of Zurich, the research team compared a